Insights on Drug Levels and Non-Sustained Viral Suppression With Long-Acting Cabotegravir and Rilpivirine Therapy

被引：0
|
作者：
Gutierrez, Felix [1 ,2 ,3 ]
Fernandez-Gonzalez, Marta [1 ,3 ]
Ledesma, Christian [1 ]
Losada-Echeberria, Maria [4 ]
Barrajon-Catalan, Enrique [4 ]
Masia, Mar [1 ,2 ,3 ]
机构：
[1] Hosp Gen Univ Elche, Infect Dis Unit, Elche, Spain
[2] Univ Miguel Hernandez, Dept Clin Med, Avda Univ S-N, Alicante 03202, Spain
[3] Inst Salud Carlos III, CIBERINFEC, Madrid, Spain
[4] Univ Miguel Hernandez, Inst Res Dev & Innovat Hlth Biotechnol Elche IDiBE, Elche, Spain
来源：
CLINICAL INFECTIOUS DISEASES | 2025年
关键词：
D O I：
10.1093/cid/ciae617
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Factors influencing the prescription of long-acting injectable dual therapy cabotegravir/rilpivirine in a Northwest Paris region cohort
    Leporrier, Jeremie
    Daneluzzi, Vincent
    Amari, Souhayla
    Bouteira, Ghania
    Dubois, Severine
    Zeng, Feng
    Bloch, Martine
    Nguisseu, Ghislaine
    Aslangul, Elisabeth
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2024, 27 : 112 - 113
  • [42] Cabotegravir plus rilpivirine long-acting as HIV-1 maintenance therapy: ATLAS Week 96 results
    Swindells, S.
    Lutz, T.
    Van Zyl, L.
    Porteiro, N.
    Benn, P.
    Huang, J.
    Harrington, C.
    Hove, K.
    Ford, S.
    Talarico, C.
    Chounta, V.
    Crauwels, H.
    Van Solingen-Ristea, R.
    Vanveggel, S.
    Margolis, D.
    Smith, K.
    Vandermeulen, K.
    Spreen, W.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2020, 23 : 19 - 21
  • [43] Real world use of long-acting cabotegravir and rilpivirine in a HIV centre in Hong Kong
    Chan, M. C. J.
    Chik, S. H. T.
    Lamb, S. S.
    Choi, Y. C. C.
    Lau, W. T. A.
    Leung, C. S. E.
    To, P. Y. L.
    Lau, P. L. D.
    Tsang, T. Y. O.
    HIV MEDICINE, 2023, 24 : 155 - 156
  • [44] Physiologically-based pharmacokinetic modelling of long-acting injectable cabotegravir and rilpivirine in pregnancy
    Atoyebi, Shakir
    Bunglawala, Fazila
    Cottura, Nicolas
    Granana-Castillo, Sandra
    Montanha, Maiara Camotti
    Olagunju, Adeniyi
    Siccardi, Marco
    Waitt, Catriona
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2024,
  • [45] Long-Acting Cabotegravir and Rilpivirine after Oral Induction for HIV-1 Infection
    Orkin, Chloe O. C.
    Arasteh, Keikawus A. K.
    Hernandez-Mora, M. Gorgolas M. G. H. M.
    Pokrovsky, Vadim P. V.
    Overton, Edgar T. O. E. T.
    Girard, Pierre-Marie G. P. M.
    Oka, Shinichi O. S.
    Walmsley, Sharon W. S.
    Bettacchi, Chris B. C.
    Brinson, Cynthia B. C.
    Philibert, Patrick P. P.
    Lombaard, Johan L. J.
    Clair, Marty C. M.
    Crauwels, Herta C. H.
    Ford, Susan L. F. S. L.
    Patel, Parul P. P.
    Chounta, Vasiliki C. V.
    D'Amico, Ronald D. R.
    Vanveggel, Simon V. S.
    Dorey, David D. D.
    Cutrell, Amy C. A.
    Griffith, Sandy G. S.
    Margolis, David A. M. D. A.
    Williams, Peter E. W. P. E.
    Parys, Wim P. W.
    Smith, Kimberly Y. S. K. Y.
    Spreen, William R. S. W. R.
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (12): : 1124 - 1135
  • [46] Long-acting Injectable Cabotegravir/Rilpivirine Effective in a Small Patient Cohort With Virologic Failure on Oral Antiretroviral Therapy
    Brock, James B.
    Herrington, Peyton
    Hickman, Melissa
    Hickman, Aubri
    CLINICAL INFECTIOUS DISEASES, 2024, 78 (01) : 122 - 124
  • [47] Use of long-acting cabotegravir plus rilpivirine during hemodialysis and solid organ transplantation
    Rezzonico, Leonardo F.
    Baldassari, Luca
    Peracchi, Francesco
    Merli, Marco
    Puoti, Massimo
    Rossotti, Roberto
    AIDS, 2023, 37 (09) : 1491 - 1493
  • [48] A new paradigm for antiretroviral delivery: long-acting cabotegravir and rilpivirine for the treatment and prevention of HIV
    Bares, Sara H.
    Scarsi, Kimberly K.
    CURRENT OPINION IN HIV AND AIDS, 2022, 17 (01) : 22 - 31
  • [49] Efficacy and safety of long-acting intramuscular cabotegravir and rilpivirine in women: a substudy of the RELATIVITY cohort
    Galindo Puerto, Maria Jose
    Cabello Clotet, Noemi
    Aldamiz-Echevarria Lois, Teresa
    Llenas-Garcia, Jara
    Mar Arcos, Mari
    Troya, Jesus
    Buzon Martin, Luis
    Torralba, Miguel
    Santacreu, Mireia
    Aguilera Garcia, Maria
    Cabello Ubeda, Alfonso
    Crusells-Canales, Maria Jose
    Morano, Luis
    Pedrero Tome, Roberto
    Martin Rico, Patricia
    Montero Hernandez, Carmen
    Perez Martinez, Desiree
    de la Fuente Moral, Sara
    Calderon Hernaiz, Ruth
    Bernal, Enrique
    Vivancos Gallego, Maria Jesus
    Antonia Sepulveda, Maria
    Cecilio, Alvaro
    Arenas Garcia, Victor
    Padilla, Sergio
    Losa Garcia, Juan Emilio
    de las Revillas Almajano, Francisco Arnaiz
    Sanchez Guirao, Antonio Jesus
    Garcia Navarro, Maria Del Mar
    Cerezales Calvino, Ana
    Garcinuno Jimenez, Maria Angeles
    Ferreira Pasos, Eva Maria
    Estebanez, Miriam
    De la Calle Riaguas, Beatriz
    Egido Murciano, Miguel
    Ramos Vicente, Noemi
    Clavero Olmos, Marta
    Manuel Tiraboschi, Juan
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2024, 27 : 75 - 76
  • [50] Cabotegravir plus rilpivirine long-acting as HIV-1 maintenance therapy: ATLAS week 96 results
    Swindells, Susan
    Lutz, Thomas
    Van Zyl, Lelanie
    Porteiro, Norma
    Benn, Paul
    Huang, Jenny O.
    Harrington, Conn M.
    Hove, Kai
    Ford, Susan L.
    Talarico, Christine L.
    Chounta, Vasiliki
    Crauwels, Herta
    Van Solingen-Ristea, Rodica
    Vanveggel, Simon
    Margolis, David A.
    Smith, Kimberly Y.
    Vandermeulen, Kati
    Spreen, William R.
    Baum, Alexander
    INFECTION, 2021, 49 (SUPPL 1) : S7 - S8
12345